Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Petros Pharmaceuticals's gross profit for the twelve months ending Dec 31, 2024 was $3.90M, down 7.0% year over year. For fiscal 2024 it was $3.90M, down 7.0% from the year before. The highest annual figure on record is $6.21M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.90M | -7.0% |
| FY2023 | Dec 31, 2023 | $4.19M | +13.2% |
| FY2022 | Dec 31, 2022 | $3.70M | -40.4% |
| FY2021 | Dec 31, 2021 | $6.21M | +12.7% |
| FY2020 | Dec 31, 2020 | $5.51M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $460.65K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.29M | +1.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.09M | -26.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.06M | -46.3% |
| Q4 FY2023 | Dec 31, 2023 | -$522.40K | – |
| Q3 FY2023 | Sep 30, 2023 | $1.27M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.48M | -58.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.97M | -1.3% |
| Q4 FY2022 | Dec 31, 2022 | -$83.23K | -104.0% |
| Q3 FY2022 | Sep 30, 2022 | -$1.74M | -150.8% |
| Q2 FY2022 | Jun 30, 2022 | $3.54M | +197.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.99M | -19.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.06M | +147.4% |
| Q1 FY2021 | Mar 31, 2021 | $3.43M | +240.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.19M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.48M | – |
| Q2 FY2020 | Jun 30, 2020 | $834.33K | – |
| Q1 FY2020 | Mar 31, 2020 | $1.01M | – |
See a number that looks wrong?